Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

VEENA R WATWE

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1417120221
CMS profile
18441
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$28,734.20

178 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

VEENA R WATWE

NPI 1417120221 · CMS profile ID 18441

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417120221?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
VEENA R WATWE, NPI 1417120221, CMS profile ID 18441. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417120221?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). VEENA R WATWE, NPI 1417120221, CMS profile ID 18441. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417120221?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
VEENA R WATWE, NPI 1417120221, CMS profile ID 18441, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 178 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1417120221?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

178 matching records · $28,734.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 178 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 178.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
BETA BIONICS, INC. $13.7509/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246814531 CMS
CeQur Corporation $5,075.0008/29/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1248979613 CMS
Abbott Laboratories $86.0808/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241103334 CMS
Abbott Laboratories $94.2808/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241103336 CMS
TOLMAR, INC. $15.9308/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237001235 CMS
Amgen Inc. $6.8108/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227132237 CMS
Amgen Inc. $0.8008/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227132239 CMS
Esperion Therapeutics, Inc. $20.9408/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243979151 CMS
Tandem Diabetes Care, Inc. $4.1508/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241309054 CMS
Axsome Therapeutics, Inc. $16.5508/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235501387 CMS
RECORDATI_RARE_DISEASES_INC. $14.5108/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181725973 CMS
Corcept Therapeutics $7.0908/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214172117 CMS
Amgen Inc. $19.1108/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228660408 CMS
Novo Nordisk Inc $6.8808/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188241749 CMS
Insulet Corporation $23.4207/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207152296 CMS
Dexcom, Inc. $19.2807/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250536944 CMS
Amgen Inc. $20.0607/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228660410 CMS
Xeris Pharmaceuticals, Inc. $22.4907/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250179610 CMS
Amgen Inc. $9.9307/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227132235 CMS
Novo Nordisk Inc $19.7007/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188764998 CMS
Corcept Therapeutics $16.2307/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214172109 CMS
Tandem Diabetes Care, Inc. $24.0007/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1241309044 CMS
Novartis Pharmaceuticals Corporation $24.6907/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200386370 CMS
Lilly USA, LLC $22.1407/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187005216 CMS
Amneal Pharmaceuticals LLC $22.0506/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1220552722 CMS
Madrigal Pharmaceuticals $44.3506/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248321347 CMS
Xeris Pharmaceuticals, Inc. $22.7406/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250179606 CMS
SANOFI-AVENTIS U.S. LLC $28.6806/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233414420 CMS
Novo Nordisk Inc $19.8106/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1188951096 CMS
Abbott Laboratories $2,400.0006/06/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240582977 CMS
Abbott Laboratories $1,200.0006/06/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240584343 CMS
Abbott Laboratories $1,200.0006/06/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240584347 CMS
Abbott Laboratories $34.0906/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241102119 CMS
Abbott Laboratories $16.8706/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241103184 CMS
Abbott Laboratories $17.2206/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241103186 CMS
Abbott Laboratories $9.0206/06/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1241104583 CMS
Ascensia Diabetes Care Us Inc. $37.3906/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225126770 CMS
Lilly USA, LLC $22.1006/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187055487 CMS
Mannkind Corporation $18.3106/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250884890 CMS
TOLMAR, INC. $14.0905/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237001213 CMS
Abbott Laboratories $800.0005/27/2025 Compensation for serving as faculty or as a speaker for a medical education program No dispute reported Delay: No
Change: NEW
06/30/2026 1240583772 CMS
Insulet Corporation $23.3205/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207146054 CMS
Xeris Pharmaceuticals, Inc. $24.9405/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250179608 CMS
Abbott Laboratories $119.4905/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240997668 CMS
Corcept Therapeutics $21.8305/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1214172097 CMS
Lilly USA, LLC $19.9805/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1187063402 CMS
Abbott Laboratories $105.7305/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240936340 CMS
Novartis Pharmaceuticals Corporation $28.3905/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200386360 CMS
Mannkind Corporation $18.1005/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250884888 CMS
ABBVIE INC. $18.4605/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204703203 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $32,273.00 292
PY2020 $11,961.49 183
PY2021 $7,960.01 165
PY2022 $5,247.94 177
PY2023 $37,439.05 256
PY2024 $33,130.51 205
PY2025 $28,734.20 178

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $298,936.54 15
PY2024 Recipient $16,028.73 4
PY2024 Principal investigator $118,016.41 8
PY2023 Recipient $254.64 1
PY2023 Principal investigator $94,029.12 3
PY2022 Principal investigator $308,272.09 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,587.00 12/31/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202535017
Principal investigator 1 Novartis Pharmaceuticals Corporation $13,703.87 12/17/2025 Non-covered Recipient Entity
NORTHWEST HOUSTON NEUROLOGY AND COMPREHENSIVE SLEEP MEDICINE CENTER
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190308632
Principal investigator 1 ABBVIE INC. $8,383.50 12/05/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529220
Principal investigator 1 ABBVIE INC. $19,449.45 11/05/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202522351
Principal investigator 1 ABBVIE INC. $17,000.55 10/09/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202514829
Principal investigator 1 ABBVIE INC. $24,595.65 09/04/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202509816
Principal investigator 1 ABBVIE INC. $27,545.40 08/06/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202502356
Principal investigator 1 ABBVIE INC. $16,100.10 07/02/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494703
Principal investigator 1 ABBVIE INC. $39,345.75 06/03/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202489271
Principal investigator 1 ABBVIE INC. $28,468.80 05/07/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483929
Principal investigator 1 ABBVIE INC. $17,053.20 04/03/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202468711
Principal investigator 1 ABBVIE INC. $10,311.30 03/07/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202459341
Principal investigator 1 ABBVIE INC. $27,309.15 02/06/2025 Non-covered Recipient Entity
ENDOCRINE AND PSYCHIATRY CENTER
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448258
Principal investigator 1 Shionogi Inc $5,215.26 01/15/2025 Non-covered Recipient Entity
CLINICAL RESEARCH SOLUTION LLC
A Phase 2, Multicenter, Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Assess the Safety and Efficacy of S-309309 in Obese Adults No dispute reported 06/30/2026 1250719822
Principal investigator 1 Novartis Pharmaceuticals Corporation $38,867.56 01/02/2025 Non-covered Recipient Entity
NORTHWEST HOUSTON NEUROLOGY AND COMPREHENSIVE SLEEP MEDICINE CENTER
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190308634